This study is testing an investigational medication for Non-Hodgkin’s Lymphoma. Qualified individuals will participate in a screening period, treatment period and follow-up period that will be discussed in more detail with the study team.
Non-Hodgkin’s Lymphoma is the cancer that originates in your lymphatic system, which is a part of the immune system that helps fight infections and other diseases. In Non-Hodgkin’s lymphoma, tumors develop from lymphocytes — a type of white blood cell that fights infection. Cancer starts when cells begin to grow out of control. Lymphomas can start anywhere in the body where lymph tissue is found as well as in the blood stream and all over the body.
Common symptoms may include:
A clinical research study tests the safety and effectiveness of a new medicine or treatment in a population of volunteers. Every medical breakthrough goes through the clinical trial process, therefore, participants like you play a very important role in advancing medicine for present and future generations.
Participation in a clinical trial allows you to take an active role in your treatment and receive study related medications, office visits, and examinations. Clinical trials contribute to medical research and help to shape future treatment options.
Protecting the health and safety of people who take part in clinical trials is the highest priority for clinical researchers throughout the entire study process. All clinical trials follow strict federal guidelines on how volunteers must be treated.
You have the right to leave a clinical trial at any time, for any reason. If you decide to leave a trial, talk to your doctor first. You will want to know how leaving the trial might affect your health and what other treatment options may be available.